No data to show
OTCM
HIRU
Market cap6mUSD
Aug 01, Last price
0.00USD
1D
3.85%
1Q
50.00%
Jan 2017
92.86%
Name
Hiru Corp
Chart & Performance
P/E
10.61
P/S
1.57
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
10.97%
Rev. gr., 5y
-56.33%
Revenues
4m
-67.62%
Net income
568k
-81.30%
CFO
947k
-26.45%
Profile
Hiru Corporation, through its subsidiary, produces Chinese herbs for the naturopathic industry in China. It manufactures herbal supplements containing ginseng. The company sells and distributes pharmaceuticals, health and beauty products, dietary and herbal supplements, and other healthcare products. It manufactures approximately 120 extracts used in traditional Chinese medicine. Hiru Corporation sells its products through regional distributors, as well as directly to the hospitals, clinics, and pharmacies in China. Hiru Corporation was formerly known as Phoenix Restaurant Group, Inc. and changed its name to Hiru Corporation in November 2008. The company is based in Phoenix, Arizona.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||
Revenues | 3,836 -67.62% | 11,845 847.80% | ||||||
Cost of revenue | 2,301 | 6,529 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 1,534 | 5,316 | ||||||
NOPBT Margin | 40.00% | 44.88% | ||||||
Operating Taxes | (168) | (228) | ||||||
Tax Rate | ||||||||
NOPAT | 1,702 | 5,544 | ||||||
Net income | 568 -81.30% | 3,036 1,808.78% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 1,000 | 232 | ||||||
BB yield | -40.00% | -5.83% | ||||||
| Debt | ||||||||
Debt current | 1,274 | 876 | ||||||
Long-term debt | 6,498 | 6,547 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | 124 | 195 | ||||||
Net debt | 6,695 | 7,395 | ||||||
| Cash flow | ||||||||
Cash from operating activities | 947 | 1,288 | ||||||
CAPEX | (849) | (6,200) | ||||||
Cash from investing activities | (849) | (5,700) | ||||||
Cash from financing activities | 951 | 5,245 | ||||||
FCF | 1,754 | 1,364 | ||||||
| Balance | ||||||||
Cash | 1,077 | 28 | ||||||
Long term investments | ||||||||
Excess cash | 886 | |||||||
Stockholders' equity | (632) | (1,200) | ||||||
Invested Capital | 10,838 | 9,560 | ||||||
ROIC | 16.69% | 69.88% | ||||||
ROCE | 15.03% | 63.59% | ||||||
| EV | ||||||||
Common stock shares outstanding | 2,941,425 | 1,941,425 | ||||||
Price | 0.00 -58.54% | 0.00 -55.43% | ||||||
Market cap | 2,500 -37.18% | 3,980 -50.51% | ||||||
EV | 9,196 | 11,375 | ||||||
EBITDA | 1,534 | 5,316 | ||||||
EV/EBITDA | 5.99 | 2.14 | ||||||
Interest | ||||||||
Interest/NOPBT | ||||||||